A point mutation that confers constitutive activity to CXCR4 reveals that T140 is an inverse agonist and that AMD3100 and ALX40-4C are weak partial agonists.

The Journal of Biological Chemistry
Wen-Bo ZhangStephen C Peiper

Abstract

CXCR4 is a G protein-coupled receptor for stromal-derived factor 1 (SDF-1) that plays a critical role in leukocyte trafficking, metastasis of mammary carcinoma, and human immunodeficiency virus type-1 infection. To elucidate the mechanism for CXCR4 activation, a constitutively active mutant (CAM) was derived by coupling the receptor to the pheromone response pathway in yeast. Conversion of Asn-119 to Ser or Ala, but not Asp or Lys, conferred autonomous CXCR4 signaling in yeast and mammalian cells. SDF-1 induced signaling in variants with substitution of Asn-119 to Ser, Ala, or Asp, but not Lys. These variants had similar cell surface expression and binding affinity for SDF-1. CXCR4-CAMs were constitutively phosphorylated and present in cytosolic inclusions. Analysis of antagonists revealed that exposure to AMD3100 or ALX40-4C induced G protein activation by CXCR4 wild type, which was greater in the CAM, whereas T140 decreased autonomous signaling. The affinity of AMD3100 and ALX40-4C binding to CAMs was less than to wild type, providing evidence of a conformational shift. These results illustrate the importance of transmembrane helix 3 in CXCR4 signaling. Insight into the mechanism for CXCR4 antagonists will allow for the devel...Continue Reading

References

Mar 29, 1994·Proceedings of the National Academy of Sciences of the United States of America·G PeiR J Lefkowitz
Dec 10, 1996·Proceedings of the National Academy of Sciences of the United States of America·J J RussoP S Moore
Sep 1, 1996·The Journal of Experimental Medicine·C C BleulT A Springer
Oct 23, 1997·The Journal of Experimental Medicine·D ScholsE De Clercq
Oct 23, 1997·The Journal of Experimental Medicine·T MurakamiT Nagasawa
Oct 28, 1998·The Journal of Clinical Investigation·M C GershengornI Clark-Lewis
Jan 27, 1999·Biochemical and Biophysical Research Communications·H TamamuraN Fujii
Aug 5, 2000·Science·K PalczewskiM Miyano
Oct 26, 2000·The Journal of Biological Chemistry·P CasarosaM J Smit
Jan 23, 2001·The Journal of Biological Chemistry·L O GerlachT W Schwartz
May 17, 2001·Proceedings of the National Academy of Sciences of the United States of America·P GhanouniB K Kobilka

❮ Previous
Next ❯

Citations

Jun 5, 2008·Naunyn-Schmiedeberg's Archives of Pharmacology·Patrick KleemannRoland Seifert
Jun 1, 2005·Trends in Biotechnology·Graham LaddsJohn Davey
Feb 1, 2003·Trends in Pharmacological Sciences·László HunyadyPatrick Vanderheyden
Sep 13, 2011·Journal of Medicinal Chemistry·Oliver DemmerHorst Kessler
Nov 10, 2010·Proceedings of the National Academy of Sciences of the United States of America·Sven JähnichenMartine J Smit
Oct 20, 2010·The Journal of Biological Chemistry·Stéphanie GravelNikolaus Heveker
Nov 13, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Kathryn E LukerGary D Luker
Apr 20, 2004·Current Opinion in Infectious Diseases·Farida Shaheen, Ronald G Collman
Jul 3, 2010·Pathology International·Bungo FurusatoJohng S Rhim
Mar 18, 2005·Annual Review of Immunology·Jason G Cyster
May 19, 2007·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Manit AryaHiten R H Patel
May 29, 2012·Molecular Medicine·Harold H BachMatthias Majetschak
Jan 22, 2011·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Ha-Yon KimDeog-Yeon Jo
Apr 12, 2014·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Takashi Nagasawa
Oct 25, 2012·Annual Review of Pharmacology and Toxicology·Silvia MontanerJ Silvio Gutkind
Dec 14, 2007·Developmental Neuroscience·Anastasia LiapiBagirathy Nadarajah
Feb 18, 2016·Bioconjugate Chemistry·Sophie PotyFranck Denat
Nov 23, 2005·Expert Opinion on Therapeutic Targets·Hirokazu Tamamura, Nobutaka Fujii
Apr 2, 2009·Expert Opinion on Investigational Drugs·Jan A Burger, David J Stewart
Jan 31, 2003·Expert Opinion on Investigational Drugs·Nobutaka FujiiHirokazu Tamamura
Jan 9, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Breanne LandryHasan Uludağ
Apr 19, 2016·Current Pharmacology Reports·Yan WangDavid Oupický
Oct 15, 2013·Critical Reviews in Oncology/hematology·Lucia LombardiEvaristo Maiello
Jul 7, 2015·Future Medicinal Chemistry·Jon VåbenøMette M Rosenkilde
Dec 9, 2010·Experimental Hematology·Katia BeiderAmnon Peled
Jul 28, 2009·Biochemical Pharmacology·Philip E BoulaisRichard Leduc
Dec 17, 2008·Seminars in Cancer Biology·Hyunsuk ShimNobutaka Fujii
Jun 2, 2009·The Journal of Surgical Research·Eugene H HuangAnthony Lucci

❮ Previous
Next ❯

Related Concepts

Related Feeds

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.